// App-Quantinova.ai

1764 : Germline MPLW515R Mutation in a Family with Isolated Thrombocytosis

Researchers

Presenter

  • Victor Gourain

Principal Investigators

  • Cedric Cleyrat

  • Delphine Feron

  • Francois Girodon

  • Nadine Morineau

  • Ashot Harutyunyan

  • Robert Kralovics

  • Sylvie Hermouet

Medical Centers

  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  • INSERM U, Institut de Recherche Therapeutique, CRCNA, Nantes, France

  • Cell Pathology Laboratories, University of New Mexico, Albuquerque, NM, USA,

  • CHU Dijon, Laboratoire dHematologie, Dijon, France

  • INSERM UMR , Nantes, France

Locations

  • France

  • United States

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Myelofibrosis

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Cluster of Differentiation 2AP

  • Thrombocytosis

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim